Literature DB >> 2452748

Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein.

F Sinigaglia1, M Guttinger, D Gillessen, D M Doran, B Takacs, H Matile, A Trzeciak, J R Pink.   

Abstract

The circumsporozoite protein of the malaria parasite Plasmodium falciparum contains regions of nonrepetitive sequences which are predicted to be T cell recognition sites. We synthesized peptides corresponding to three of these regions, and tested their ability to stimulate proliferation of peripheral blood lymphocytes from donors living in a malaria-endemic area, or from nonimmune donors. Cells from 15 out of 22 donors (including 4 of 6 nonimmune individuals) were stimulated by one or more of the peptides. T cell clones specific for one of the peptides were obtained and shown to recognize the native protein purified from sporozoites. These data help to identify T cell epitopes which could be incorporated into a malaria vaccine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452748     DOI: 10.1002/eji.1830180422

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

Authors:  L Schofield
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.

Authors:  F A Kironde; K V Rao; S Shah; A Kumar; N Sahoo
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

3.  Gold-specific T cells in rheumatoid arthritis patients treated with gold.

Authors:  P Romagnoli; G A Spinas; F Sinigaglia
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice.

Authors:  Alberto Pinzon-Charry; Virginia McPhun; Vivian Kienzle; Chakrit Hirunpetcharat; Christian Engwerda; James McCarthy; Michael F Good
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

5.  Vaccine T-cell epitope selection by a peptide competition assay.

Authors:  J Kilgus; P Romagnoli; M Guttinger; D Stuber; L Adorini; F Sinigaglia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.

Authors:  D A Herrington; D F Clyde; J R Davis; S Baqar; J R Murphy; J F Cortese; R S Bank; E Nardin; D DiJohn; R S Nussenzweig
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

7.  T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes.

Authors:  S L Hoffman; D Isenbarger; G W Long; M Sedegah; A Szarfman; S Mellouk; W R Ballou
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

8.  Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.

Authors:  A R Lussow; G Del Giudice; L Rénia; D Mazier; J P Verhave; A S Verdini; A Pessi; J A Louis; P H Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.

Authors:  Aissatou Toure-Balde; Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Mouhamadou Ndiaye; Georgette Aribot; Adama Tall; Cheikh Sokhna; Christophe Rogier; Giampietro Corradin; Christian Roussilhon; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

10.  Human T cells recognize polymorphic and non-polymorphic regions of the Plasmodium falciparum circumsporozoite protein.

Authors:  M Guttinger; P Caspers; B Takacs; A Trzeciak; D Gillessen; J R Pink; F Sinigaglia
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.